
Overview
"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.".
Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer.
His clinical research consists of participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5255 Loughboro Road Northwest, Washington, DC 20016
6420 Rockledge Drive, Suite 1200, Bethesda, MD 20817
5255 Loughboro Road Northwest, Washington, DC 20016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
10 Clinical Trials
University Of Maryland Radiation Oncology Associates PA
Vinita Patanaphan is a Radiation Oncologist in Baltimore, Maryland. Dr. Patanaphan is rated as an Advanced provider by MediFind in the treatment of Primary Lymphoma of the Brain. Her top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Prostate Cancer, and Familial Prostate Cancer. Dr. Patanaphan is currently accepting new patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Chengcheng Gui is an instructor in the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins University School of Medicine. His clinical focus is the use of radiotherapy to treat head and neck cancers, as well as skin cancers. Dr. Gui obtained his medical degree from the Johns Hopkins University School of Medicine and completed his residency training at Memorial Sloan Kettering Cancer Center, where he served as chief resident and received the Radiation Oncology Medical Student Teaching Award. Dr. Gui believes that cancer patients deserve a clear and thorough understanding of the benefits and risks of their treatment options, empowering them to choose the path that best aligns with their personal values. To support this, Dr. Gui is committed to being an approachable, trustworthy source of information, while also planning and delivering high-quality radiotherapy. Research Summary Dr. Gui's research focuses on enhancing the safety and effectiveness of radiotherapy by integrating multiple data modalities. His work incorporates advanced structural and functional imaging, tumor molecular characteristics, and patient-reported outcomes to inform and personalize treatment approaches. Selected Publications Gui C, Wray R, Schöder H, Deasy JO, Grkovski M, Humm JL, Wong RJ, Sherman EJ, Riaz N, Lee NY. Tumor hypoxia on 18F-fluoromisonidazole positron emission tomography and distant metastasis from head and neck squamous cell carcinoma. JAMA Network Open. 2024 Sep 3;7(9):e2436407-. Gui C, Walch H, Mueller K, Boe L, Skakodub A, Miao E, Khatri I, Kumar R, Padilla Mazzeo, Shen J, Cooper C, Parker M, Hsu A, Patel R, Ilica AT, Stember JN, Eichholz JE, Bou Nassif R, Yu KKH, Wilcox JA, Manca P, Yu Y, Yamada Y, Imber BS, Maron SB, Foote MB, Chatila WK, Yaeger R, Schultz N, Pike LRG. Genomics correlates of brain metastasis and progression in colorectal cancer. Neuro-Oncology. 2025 Aug 28:noaf198. doi: 10.1093/neuonc/noaf198. Online ahead of print. Gui C, Vannorsdall TD, Kleinberg LR, Assadi R, Moore JA, Hu C, Quiñones-Hinojosa A, Redmond KJ. A prospective cohort study of neural progenitor cell-sparing radiation therapy plus temozolomide for newly diagnosed patients with glioblastoma. Neurosurgery. 2020 Jul 1;87(1):E31-40. Redmond KJ, Gui C, Benedict S, Milano MT, Grimm J, Vargo JA, Soltys SG, Yorke E, Jackson A, El Naqa I, Marks LB. Tumor control probability of radiosurgery and fractionated stereotactic radiosurgery for brain metastases. International Journal of Radiation Oncology* Biology* Physics. 2021 May 1;110(1):53-67. Eitz KA, Lo SS, Soliman H, Sahgal A, Theriault A, Pinkham MB, Foote MC, Song AJ, Shi W, Redmond KJ, Gui C, Kumar AMS, Machtay M, Meyer B, Combs SE. Multi-institutional analysis of prognostic factors and outcomes after hypofractionated stereotactic radiotherapy to the resection cavity in patients with brain metastases. JAMA Oncology. 2020 Dec 1;6(12):1901-9. Dr. Gui is rated as an Experienced provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Brain Tumor, Primary Lymphoma of the Brain, Myxoid Liposarcoma, Endoscopy, and Osteotomy.
Radiation Oncology Associates PC
Gopal Bajaj is a Radiation Oncologist in Falls Church, Virginia. Dr. Bajaj is rated as a Distinguished provider by MediFind in the treatment of Primary Lymphoma of the Brain. His top areas of expertise are Adenoid Cystic Carcinoma, Pleuropulmonary Blastoma, Breast Cancer, Metastatic Brain Tumor, and Gastrostomy. Dr. Bajaj is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Pancreatic CancerDr. Kumar isDistinguished. Learn about Pancreatic Cancer.
- Advanced
- Familial Pancreatic CancerDr. Kumar isAdvanced. Learn about Familial Pancreatic Cancer.
- Familial Prostate CancerDr. Kumar isAdvanced. Learn about Familial Prostate Cancer.
- GliomaDr. Kumar isAdvanced. Learn about Glioma.
- Lung CancerDr. Kumar isAdvanced. Learn about Lung Cancer.
- Metastatic Brain TumorDr. Kumar isAdvanced. Learn about Metastatic Brain Tumor.
- PancreatoblastomaDr. Kumar isAdvanced. Learn about Pancreatoblastoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Kumar isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Kumar isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Kumar isExperienced. Learn about Angiosarcoma.
- AstrocytomaDr. Kumar isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
